References
- Schachter M. Erectile dysfunction and lipid disorders. Curr Med Res Opin 2000;16:S9–S12
- Sullivan ME, Keoghane SR, Miller MA. Vascular risk factors and erectile dysfunction. Br J Urol Int 2001;87:838–45
- Billups K, Friedrich S. Assessment of fasting lipid panels and Doppler ultrasound testing in men presenting with erectile dysfunction and no other medical problems. J Urol 2000;163(Suppl):147
- Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994;151:54–61
- Greenstein A, Chen J, Miller H, et al. Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 1997;9:123–6
- Feldman HA, Johannes CB, Derby CA, et al. Erectile dys-function and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med 2000;30:328–38
- Thompson I, Tangen C, Goodman P, et al. Erectile dysfunction and subsequent cardiovascular disease. J Am Med Assoc 2005;294:2996–3002
- Wei M, Macera CA, Davis DR, et al. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am J Epidemiol 1994;140:930–7
- Seftel AD, Vaziri ND, Ni Z, et al. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS. Urology 1997;50:1016–26
- De Angelis L, Marfella MA, Siniscalchi M, et al. Erectile and endothelial dysfunction in Type II diabetes: a possible link. Diabetologia 2001;44:1155–60
- Taddei S, Virdis A, Ghiadoni L, et al. Endothelial dysfunction in hypertension: fact or fancy? J Cardiovasc Pharmacol 1998;32: S41–S47
- Kirby M, Jackson G, Betteridge J, et al. Is erectile dysfunction a marker for cardiovascular disease? Int J Clin Pract 2001;55: 614–8
- el-Sakka AI, Tayeb KA. Erectile dysfunction risk factors in noninsulin dependent diabetic Saudi patients. J Urol 2003;169:1043–7
- Fedele D, Coscelli C, Santeusanio F, et al. Erectile dysfunction in diabetic subjects in Italy [Gruppo Italiano Studio Deficit Erettile nei Diabetici]. Diabetes Care 1998;21:1973–7
- Fedele D, Bortolotti A, Coscelli C, et al. Erectile dysfunction in type 1 and type 2 diabetics in Italy [On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici]. Int J Epidemiol 2000;29:524–31
- Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319–26
- Glasser DB, Pritchett JJ. NASCAR races: a targeted venue for health screening and identification of men and women at risk for diabetes. Diabetes 2002;51:A225–A226
- DeWire DM. Evaluation and treatment of erectile dysfunction. Am Fam Physician 1996;53:2101–8
- Rendell MS, Rajfer J, Wicker PA, et al. Sildenafil for treatment of erectile dysfunction in men with diabetes. J Am Med Assoc 1999;281:421–6
- Boulton AJ, Selam JL, Sweeney M, et al. Sildenafil citrate for the treatment of erectile dysfunction in men with type II diabetes mellitus. Diabetologia 2001;44:1296–301
- Stuckey BG, Jadzinsky MN, Murphy LJ, et al. Sildenafil citrate for treatment of erectile dysfunction in men with type 1 diabetes: results of a randomized controlled trial. Diabetes Care 2003;26:279–84
- Rosen RC, Riley A, Wagner G, et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822–30
- Cappelleri JC, Rosen RC, Smith MD, et al. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999;54:346–51
- Glina S, Bertero E, Claro J, et al. Efficacy and safety of sildenafil citrate for the treatment of erectile dysfunction in Latin America. Braz J Urol 2001;27:148–54
- Carson CC, Burnett AL, Levine LA, et al. The efficacy of sildenafil citrate (Viagra®) in clinical populations: an update. Urology 2002;60(Suppl 2B):12–27
- Tan HM, Moh CL, Mendoza JB, et al. Asian sildenafil efficacy and safety study (ASSESS-1): a double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction [The Assess-1 Study Group]. Urology 2000;56:635–40
- Chen KK, Hsieh JT, Huang ST, et al. ASSESS-3: a randomised, double-blind, flexible-dose clinical trial of the efficacy and safety of oral sildenafil in the treatment of men with erectile dysfunction in Taiwan. Int J Impot Res 2001;13:221–9
- Kongkanand A, Ratana-Olarn K, Ruangdilokrat S, et al. The efficacy and safety of oral sildenafil in Thai men with erectile dysfunction: a randomized, double-blind, placebo controlled, flexible-dose study. J Med Assoc Thai 2003;86:195–205
- Dinsmore WW, Hodges M, Hargreaves C, et al. Sildenafil citrate (VIAGRA) in erectile dysfunction: near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects. Urology 1999;53:800–5
- Cappelleri JC, Siegel RL, Osterloh IH, et al. Relationship between patient self-assessment of erectile function and the erectile function domain of the international index of erectile function. Urology 2000;56:477–81
- Seidman SN, Roose SP, Menza MA, et al. Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry 2001;158:1623–30
- Hirsch IB, Korenman SG, Stecher V, et al. Viagra® (sildenafil citrate): efficacy and safety in the treatment of erectile dys-function (ED) in men with diabetes. Diabetes 1999;48\(Suppl 1):A90, Abstract 0388
- Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. New Engl J Med 1998;338:1397–404
- Derry FA, Dinsmore WW, Fraser M, et al. Efficacy and safety of oral sildenafil (VIAGRA) in men with erectile dysfunction caused by spinal cord injury. Neurology 1998;51:1629–33
- Fava M, Nurnberg HG, Seidman SN, et al. Efficacy and safety of sildenafil citrate (Viagra®) in men with serotonergic antidepressant-associated erectile dysfunction: Results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2006;67:240–6
- Kadioglu A, Erdogru T, Karsidag K, et al. Evaluation of penile arterial system with color Doppler ultrasonography in nondiabetic and diabetic males. Eur Urol 1995;27:311–4
- Saenz de Tejada I, Goldstein I, Azadzoi K, et al. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. New Engl J Med 1989;320:1025–30
- Keene LC, Davies PH. Drug-related erectile dysfunction. Adverse Drug React Toxicol Rev 1999;18:5–24
- Padma-Nathan H. Sildenafil citrate (Viagra®) treatment for erectile dysfunction: an updated profile of response and effectiveness. Int J Impot Res 2006;18:423–31
- Morales A, Gingell C, Collins M, et al. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int J Impot Res 1998;10:69–74
- Giuliano F, Porst H, Hedelin H, et al. Cardiovascular safety of Viagra® (sildenafil citrate): results of the international men’s health study. Eur Urol 2005;4(Suppl 3):137
- Jackson G, Montorsi P, Cheitlin MD. Cardiovascular safety of sildenafil citrate (Viagra®): an updated perspective. Urology 2006;68(Suppl):48–60